Igor Bilinsky is COO at IOVANCE BIOTHERAPEUTICS, INC. (IOVA). They have made 1 open-market trade across 1 company since 2014, most recently 2026-09-08.
CIK 0001594604
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $128K since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VICL | SELL · 10b5-1 | 2015-07-13 | 2015-07-15 | $0.70 | $881 | -15.9% | +10.5% | +10.5% |
| VICL | SELL · 10b5-1 | 2015-04-13 | 2015-04-15 | $0.93 | $1K | -15.9% | +10.5% | +10.5% |
| VICL | SELL · 10b5-1 | 2015-01-12 | 2015-01-14 | $1.16 | $2K | -15.9% | +10.5% | +10.5% |
| VICL | SELL · 10b5-1 | 2014-10-13 | 2014-10-14 | $1.08 | $1K | -15.9% | +10.5% | +10.5% |
| VICL | SELL · 10b5-1 | 2014-08-26 | 2014-08-27 | $1.25 | $16K | -15.9% | +10.5% | +10.5% |
| VICL | SELL · 10b5-1 | 2014-07-11 | 2014-07-15 | $1.16 | $2K | -15.9% | +10.5% | +10.5% |
| VICL | SELL · 10b5-1 | 2014-04-11 | 2014-04-14 | $1.21 | $1K | -15.9% | +10.5% | +10.5% |
| VICL | BUY | 2014-01-10 | 2014-01-14 | $1.42 | $128K | -15.9% | +10.5% | +10.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.